[Long-term drug prevention of cardiovascular diseases (methodological aspects)].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000517:prevention & control; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000517:prevention & control; D006973:Hypertension / Q000517:prevention & control*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents; D005996:Nitroglycerin
Dlitel'naia medikamentoznaia profilaktika serdechno-sosudistykh zabolevaniĭ (metodologicheskie aspekty).